198 related articles for article (PubMed ID: 20363332)
21. Construction, expression, and characterization of a new targeted bifunctional fusion protein: tumstatin45-132-TNF.
Luo YQ; Wang LH; Ma XL; Kong JX; Jiao BH
IUBMB Life; 2006 Nov; 58(11):647-53. PubMed ID: 17085384
[TBL] [Abstract][Full Text] [Related]
22. SUMO fusion facilitates expression and purification of garlic leaf lectin but modifies some of its properties.
Upadhyay SK; Saurabh S; Rai P; Singh R; Chandrashekar K; Verma PC; Singh PK; Tuli R
J Biotechnol; 2010 Mar; 146(1-2):1-8. PubMed ID: 20100526
[TBL] [Abstract][Full Text] [Related]
23. High-yield expression and purification of soluble forms of the anti-apoptotic Bcl-x(L) and Bcl-2 as TolAIII-fusion proteins.
Nedelkina S; Gokce I; Ridley H; Weckerle C; Magnin T; Vallette F; Pattus F; Lakey JH; Bechinger B
Protein Expr Purif; 2008 Aug; 60(2):214-20. PubMed ID: 18522870
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of fermentation media and optimization of expression conditions for the production of EAK(16) peptide as fusions with SUMO.
Satakarni M; Koutinas AA; Webb C; Curtis R
Biotechnol Bioeng; 2009 Feb; 102(3):725-35. PubMed ID: 18973282
[TBL] [Abstract][Full Text] [Related]
25. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner.
Tomala M; Lavrentieva A; Moretti P; Rinas U; Kasper C; Stahl F; Schambach A; Warlich E; Martin U; Cantz T; Scheper T
Protein Expr Purif; 2010 Sep; 73(1):51-7. PubMed ID: 20381622
[TBL] [Abstract][Full Text] [Related]
26. Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factor.
Tsuji Y; Kitahara-Tanabe N; Noguchi K; Gatanaga T; Mizuno D; Soma G
Biochem Int; 1989 Mar; 18(3):501-8. PubMed ID: 2669759
[TBL] [Abstract][Full Text] [Related]
27. Heterologous expression of Translocated promoter region protein, Tpr, identified as a transcription factor from Rattus norvegicus.
Agarwal S; Yadav SK; Dixit A
Protein Expr Purif; 2011 May; 77(1):112-7. PubMed ID: 21216290
[TBL] [Abstract][Full Text] [Related]
28. High cell density cultivation of recombinant Escherichia coli for prodrug of recombinant human GLPs production.
Zhou Y; Ma X; Hou Z; Xue X; Meng J; Li M; Jia M; Luo X
Protein Expr Purif; 2012 Sep; 85(1):38-43. PubMed ID: 22771632
[TBL] [Abstract][Full Text] [Related]
29. Production of an Arabidopsis halleri foliar defensin in Escherichia coli.
Marquès L; Oomen RJ; Aumelas A; Le Jean M; Berthomieu P
J Appl Microbiol; 2009 May; 106(5):1640-8. PubMed ID: 19226399
[TBL] [Abstract][Full Text] [Related]
30. [An effective method of purifying recombinant human tumor necrosis factor alpha].
Tikhonov RV; Iakimov SA; Korobko VG; Vul'fson AN
Bioorg Khim; 1996 Mar; 22(3):163-7. PubMed ID: 8687507
[TBL] [Abstract][Full Text] [Related]
31. Expression in Escherichia coli of the death domain of the human p55 tumor necrosis factor receptor.
De Wilde G; Mertens N; Boone E; De Vreese B; Van Beeumen J; Fiers W; Haegeman G
Protein Expr Purif; 2001 Nov; 23(2):226-32. PubMed ID: 11676596
[TBL] [Abstract][Full Text] [Related]
32. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography.
Küster B; Wheeler SF; Hunter AP; Dwek RA; Harvey DJ
Anal Biochem; 1997 Jul; 250(1):82-101. PubMed ID: 9234902
[TBL] [Abstract][Full Text] [Related]
33. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems.
Panavas T; Sanders C; Butt TR
Methods Mol Biol; 2009; 497():303-17. PubMed ID: 19107426
[TBL] [Abstract][Full Text] [Related]
34. Expression and purification of soluble B lymphocyte stimulator from recombinant Escherichia coli.
Guo QR; Tong WY; Wei DZ; Tao XY
Prikl Biokhim Mikrobiol; 2008; 44(2):187-92. PubMed ID: 18669261
[TBL] [Abstract][Full Text] [Related]
35. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
36. Non-fusion expression in Escherichia coli, purification, and characterization of a novel Ca2+- and phospholipid-binding protein annexin B1.
Zhang Y; Guo YJ; Sun SH; Yan HL; He Y
Protein Expr Purif; 2004 Mar; 34(1):68-74. PubMed ID: 14766301
[TBL] [Abstract][Full Text] [Related]
37. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli.
Zucker K; Lu P; Fuller L; Asthana D; Esquenazi V; Miller J
Lymphokine Cytokine Res; 1994 Jun; 13(3):191-6. PubMed ID: 7948427
[TBL] [Abstract][Full Text] [Related]
38. SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes.
Peroutka Iii RJ; Orcutt SJ; Strickler JE; Butt TR
Methods Mol Biol; 2011; 705():15-30. PubMed ID: 21125378
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, purification and bioactivity of recombinant human activin A expressed in the yeast Pichia pastoris.
Papakonstantinou T; Harris SJ; Fredericks D; Harrison C; Wallace EM; Hearn MT
Protein Expr Purif; 2009 Apr; 64(2):131-8. PubMed ID: 19027859
[TBL] [Abstract][Full Text] [Related]
40. Production enhancement and refolding of caprine growth hormone expressed in Escherichia coli.
Khan MA; Sadaf S; Sajjad M; Waheed Akhtar M
Protein Expr Purif; 2009 Nov; 68(1):85-9. PubMed ID: 19477280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
